Navigation Links
UT awarded NIH grants to study prevention and treatment of neurodegenerative and vascular diseases
Date:9/21/2011

The National Institutes of Health (NIH) has awarded researchers at The University of Texas at Austin two highly competitive research grants to create novel therapeutics for treating heart disease as well as to develop technology that significantly reduces the time and costs required to test drugs for neurodegenerative disease.

The grants are part of a $143.8 million funding initiative provided by NIH this year to 79 researchers around the nation. The awards are granted under three innovative research programs supported by the NIH Common Fund: the NIH Director's Pioneer, New Innovator and Transformative Research Projects Awards.

"The awards are intended to catalyze giant leaps forward for any area of biomedical research, allowing investigators to go in entirely new directions," said James M. Anderson, director of the NIH Division of Program Coordination, Planning and Strategic Initiatives, who guides the Common Fund's High-Risk Research program.

Cockrell School of Engineering Associate Professor Adela Ben-Yakar and College of Natural Sciences Assistant Professor Jon Pierce-Shimomura were selected to receive the Transformative Research Project award for their research to prevent degeneration of the nervous system. Degeneration, which occurs through natural aging and diseases like Alzheimer's, has become a pervasive and growing problem in the last century due to new treatments that extend lifespan but cannot prevent neurological decline.

"We can treat cancer when we diagnose it on time and maybe find solutions for heart problems, but when it comes to the brain we don't have many effective solutions," said Ben-Yakar, from the Department of Mechanical Engineering whose mother has Alzheimer's disease. "[Neurodegeneration] is a big problem for all of humanity. As an engineer, it excites me to find new ways of doing things, but the end result is what really motivates me and my colleague."

A huge barrier to preventing or treating diseases like Alzheimer's disease is the amount of time it takes to identify drugs that work effectively. Typically, drugs are tested on mice a process that is expensive and requires one to two years for mice to age while testing just a few dozen drugs at a time. With the grant, Ben-Yakar and Pierce-Shimomura will develop an automated system that rapidly reduces this time and cost. Instead of mice, the researchers will use a short-lived, 1 mm-long worm, known as C. elegans, to test the effectiveness of millions of drugs. The researchers will also develop novel optical techniques and microfluidic devices that are capable of determining within a matter of seconds which drugs are effective.

"This award will enable our ambitious project to use advanced engineering techniques to analyze how millions of drugs may prevent neurons from dying in neurodegenerative disease," said Pierce-Shimomura, an assistant professor in the Section of Neurobiology who has a son with Down syndrome, a condition that predisposes him to Alzheimer's disease. "A drug screen of this size has never been attempted."

Aaron Baker, an assistant professor in the Department of Biomedical Engineering, has also been selected as one of the 49 scientists and engineers around the country to receive a NIH Director's New Innovator Award.

This prestigious award is designed to support unusually creative new investigators with highly innovative research ideas at an early stage of their career.

Baker will receive $1.5 million over five years to study and develop innovative ways to regrow small blood vessels in the heart. The ability to regrow the vessels could prove crucial to treating chronic myocardial ischemia disease, which affects up to 27 million patients in the U.S. and leads to a reduction of blood flow in the heart and, ultimately, causes organ dysfunction and failure.

The disease has traditionally been treated by physically opening the artery or surgically rerouting blood flow to the poorly perfused tissue. Both methods have limitations, however, and are not effective long-term.

With the NIH grant, Baker will study why previous attempts to restore blood flow to the heart have not been effective. His research aims to design new molecular tools and drug delivery methods to enable blood vessel growth in patients with diseases such as diabetes.

"Together, the studies performed and the tools developed will increase our understanding of how tissues become resistant to revascularization therapies and may lead to more effective treatments for this widespread and debilitating disease," Baker said.


'/>"/>

Contact: Melissa Mixon
melissa.mixon@austin.utexas.edu
512-471-2129
University of Texas at Austin
Source:Eurekalert

Related medicine news :

1. Major grant awarded for HIV prevention study in Africa
2. Cleveland Clinic researchers awarded NIH grant to study concussion-identifying blood test
3. University Hospitals Case Medical Center awarded 2011 fellowship awards for pain medicine, epilepsy
4. Harvard School of Public Health awarded $12 million grant to improve global maternal health
5. St. Michaels echocardiology lab awarded international seal of approval
6. Johns Hopkins Evidence-based Practice Center awarded $475,000 project
7. University Hospitals Neuromuscular Center EMG labs awarded accreditation
8. Wayne State University awarded $3 million from NIH to foster science and research careers
9. University of Houston student awarded Hogg Foundation Scholarship
10. BUSM/BMC researchers awarded $3.5 million grant from the NIDA
11. 5 awarded ASTRO research grants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/13/2016)... ... 13, 2016 , ... With FCPX Overlay Embers from Pixel Film Studios users ... Pro X. Each user can select from up to 40 effect overlays. With FCPX ... offset, hue, saturation, value, contrast, glow, and more all within a click of a ...
(Date:2/13/2016)... Lake City, Utah (PRWEB) , ... February 13, 2016 , ... When an Au ... Host Parents aren’t always sure what they are in for and they are often worried ... are more than they were hoping for. This year’s Au Pair of the Year winner’s ...
(Date:2/12/2016)... ... , ... Mystic Buddha Publishing House presents Valentine’s Day tips on different forms ... - Dr. Frederick Lenz. , According to Publisher Roger Cantu, “Blue Skies ... teaching and helping others. Valentine’s Day celebrates love in all its forms, and ...
(Date:2/12/2016)... Falls Church, VA (PRWEB) , ... February 12, 2016 , ... CDRH Enforcement Trends: , ... http://www.fdanews.com/cdrhenforcementtrends , As Winston Churchill said, “Those who don’t learn ... 2015 will show what to expect when they come knocking this year. But that takes ...
(Date:2/12/2016)... CITY, California (PRWEB) , ... February 12, 2016 , ... ... announce their participation in Red Carpet Events LA GRAMMY’s Style Lounge Event. Coco Libre ... healthy way to stay hydrated before the big event. The invitation-only gifting suite, held ...
Breaking Medicine News(10 mins):
(Date:2/11/2016)... Stem cells are primitive cells found in ... the capacity to differentiate into mature cell types Stem ... first mouse embryonic stem cells were derived from embryos ... the first culturing of embryonic stem cells from non-human ... until 2006 As a result of these discoveries, stem ...
(Date:2/11/2016)... 2016  Walgreens has committed to provide drug disposal ... Washington, D.C. as part of a program ... by shareholder advocacy organization As You Sow. Conrad ... people hold on to unneeded drugs because they lack easily ... --> Conrad MacKerron , Senior Vice President ...
(Date:2/11/2016)... Feb. 11, 2016  NOIT™ Research LLC, a private, ... of Change" campaign to assist needy families in obtaining ... unit sold between February 10, 2016 and March 31, ... needy family. The NOIT is an auditory stimulus that ... develop language skills. Beth Shier , ...
Breaking Medicine Technology: